SlideShare a Scribd company logo
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
Advanced EMT
A Clinical-Reasoning Approach, 2nd Edition
Chapter 11
Principles of
Pharmacology
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
• The Advanced EMT applies fundamental
knowledge of medications in the Advanced EMT
scope of practice to patient assessment and
management.
Advanced EMT
Education Standard
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
1. Define key terms introduced in this chapter.
2. Give examples of each of the four sources of drugs.
3. Explain the role of the U.S. Food and Drug Administration
in the development and continued oversight of drugs.
4. Discuss relevant legislation regarding the administration
of prescription medications, including controlled
substances.
5. Identify the official, generic, and trade names of drugs in
the Advanced EMT scope of practice.
Objectives (1 of 3)
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
6. Describe the various forms in which drugs are supplied.
7. Describe the various types of medication packaging.
8. Explain each of the components of a drug profile.
9. Explain each of the following with respect to
pharmacology: drug absorption, drug distribution,
mechanism of action, and drug elimination.
10.Explain the roles of the kidneys and liver in drug
metabolism and excretion.
Objectives (2 of 3)
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
11.Explain factors that can affect the concentration of a drug
in a patient’s body.
12.Describe the concepts of drug receptor sites and protein
binding of medications.
13.Identify special populations in whom the administration of
drugs may need to be modified.
Objectives (3 of 3)
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
• AEMTs are responsible for administering
medications to ill and injured patients
• Some medications, administered incorrectly,
produce life-threatening consequences
• Must have understanding of pharmacology
• Pharmacology
– Study of origin, nature, properties, actions of drugs and
their effects on living organisms
Introduction
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
• What are some initial hypotheses about the cause
of the problem?
• What additional information would assist Mike and
Matt in determining the cause of the patient’s
condition?
• What initial steps in management should the crew
members take as they finish their assessment?
Think About It
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
• Four basic sources of medications
– Plant
– Animal
– Mineral
– Synthetic
Medication Sources
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
• Discovered in 1921, insulin has saved the lives of
15 million people with diabetes
• Insulin is mainly derived from the pancreas of pigs
and cows
Think About It
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
• Keep knowledge current by reviewing new
medication information
• Be familiar with reliable, up-to-date sources
– Physician’s Desk Reference (PDR)
– American Medical Association (AMA) drug evaluations
– Hospital Formulary
Medication Reference Material
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
• Consists of
– Medication name
– Classification
– Mechanism of action
– Indications
– Pharmacokinetics
– Side effects
– Routes of administration
– Contraindications
– Dose
– How the drug is supplied
– Special considerations
Medication Profile (1 of 5)
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
• Medication name
– Generic name
– Trade name
– Chemical name
• Classification
– Type of medication it is
– Different classification schemes used
– Mechanism of action
– Body system it works within
Medication Profile (2 of 5)
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
• Mechanism of action
– Way medication achieves its intended effects
• Indications
– Conditions that medication intended to treat
• Pharmacokinetics
– How the drug is absorbed, distributed to tissues,
eliminated from the body
• Side effects
– Unintended effects of medication
Medication Profile (3 of 5)
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
• Route of administration
– Way medication introduced into the body
• Contraindications
– Makes administration of drug harmful, even though
otherwise indicated for the medical problem
• Dose
– Amount and frequency of medication to be
administered
Medication Profile (4 of 5)
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
• How supplied
– Packaging and concentrations available
• Special considerations
– Special precautions to be observed when administering
drug to special patient populations
Medication Profile (5 of 5)
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
Medication Oversight and Regulation (1
of 6)
• Legislation
– Protect the public from unsafe and mislabeled
medications
• The Harrison Narcotic Act of 1914
– Regulations on importation, manufacture, sale, and use
of medications
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
Medication Oversight and Regulation (2
of 6)
• The Food, Drug, and Cosmetic Act of 1938
– Provided additional protection to the public
– Revised in 1952 and 1962
– Provided for:
 Formation of FDA
 Mandated prescriptions required for addictive or harmful
medications
 Required labeling of medications that include addictive drugs
and potential side effects
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
Medication Oversight and Regulation (3
of 6)
• Durham-Humphrey Amendments were added to
1938 Act
– Added in 1951
– Required pharmacists to dispense certain medication
only by prescription
– Defined OTC medications
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
Medication Oversight and Regulation (4
of 6)
• The Comprehensive Drug Abuse Prevention and
Control Act of 1970
– Aka Controlled Substances Act
– Replaced the Harrison Narcotic Act of 1914
– Includes five schedules of controlled substances based
upon their potential for abuse
– Schedule I drugs have highest potential while Schedule
IV drugs have least potential
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
Table 11-1 (1 of 2)
Schedules of Controlled Substances
Schedule I
Schedule I medications have a high potential for abuse
and do not have any recognized medical use in the
United States.
Examples: heroin, LSD, mescaline, methaqualone
Schedule II
Schedule II medications have a high potential for abuse but
also have a recognized medical use in the United States.
These medications require a written prescription, are
restricted from phone renewals, and require oversight by a
physician.
Abuse may result in severe physical or psychological
dependence.
Examples: morphine, codeine, meperidine, hydrocodone,
and a host of very addictive stimulants and depressants
Schedule III
Schedule III medications have less abuse potential than
Schedule II medications and an accepted medical use.
Abuse can result in moderate to low physical or
psychological dependence.
Examples: anabolic steroids, nonprescription painkillers
combined with small amounts of Schedule II substances
such as acetaminophen with codeine or hydrocodone; also
medications that contain small amounts of opiates
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
Table 11-1 (2 of 2)
Schedules of Controlled Substances
SCHEDULE IV
Schedule IV medications have less abuse potential
than Schedule III medications and an accepted
medical use.
Abuse can result in less physical or psychological
dependence than drugs in Schedule III.
Examples: benzodiazepines, some barbiturates,
steroids, stimulants
SCHEDULE V
Schedule V medications have less abuse potential
than Schedule IV medications and an accepted
medical use.
Abuse can result in less physical or psychological
dependence than drugs in Schedule IV.
Examples: over-the-counter (OTC) medications for
cough or antidiarrheal medications that contain
small amounts of controlled substances
Source: U.S. Drug Enforcement Administration. n.d. “Drug Scheduling.” A Drug Info page on the DEA
website. http://www.dea/gov/druginfo/ds.shtml
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
• Medication safety and regulation
– The FDA is responsible for testing new medications;
food safety; testing of new medical devices; cosmetics
safety
– Testing phases
 Phase I
 Phase II
 Phase III
 Phase IV
Medication Oversight and Regulation (5
of 6)
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
• Special considerations
– Pregnant patient
 Changes in anatomy and physiology
 Risk to the fetus
– Pediatric patients
 Physical differences between adult and child
 Differences on how medications affect children
 Pediatric drug dosing based on weight of patient
– Geriatric patients
 Differences in absorption, distribution, metabolism, and
elimination of medication
 Multiple medical conditions requiring medications
Medication Oversight and Regulation (6
of 6)
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
Table 11-2
FDA Pregnancy Categories
Category Description
A Studies have not identified a risk to the fetus during pregnancy.
B Animal studies have not identified a risk to the fetus but there are no adequate
human studies.
OR
Adequate studies in humans have not demonstrated a risk to the fetus during
pregnancy but animal studies have produced adverse effects.
C Animal studies have demonstrated adverse effects but there are no adequate
studies in pregnant women; however, benefits may be acceptable despite the
potential risks.
OR
No adequate animal studies or adequate studies of pregnant women have been
performed.
D Studies have shown risk to the fetus. In some situations, benefits could outweigh
the risks.
X Studies have shown risk to the fetus. This risk outweighs any potential benefit to
the mother. Avoid using these medications in pregnant or potentially pregnant
patients.
Source: Gunatilake, R,, and A. S. Patel. n.d. “Drugs in Pregnancy.” A Gynecology and Obstretrics
page on the Merck Manual Professional Version website. Last updated January
2013. http://www.merckmanuals.com
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
Medication Names
• Trade name
– Proventil ®
• Chemical name
– α1 [(tert-butyl amino) methyl]-4-hydroxy-m-
xylene-α,α,́-diol sulfate (2:1) (salt)
• Generic name
– Albuterol sulfate
• Official name
– Albuterol sulfate USP
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
• Solid medications
– Tablet
– Capsule
– Powder
Medication Forms (1 of 3)
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
Medication Forms (2 of 3)
• Liquid medications
– Suspensions
– Tinctures
– Spirits
– Elixirs
– Syrups
– Emulsions
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
• Semisolid medications
– Lotions
– Creams
– Gels
– Ointments
– Medicated adhesive patches
• Gases
– Oxygen
– Nitrous oxide
Medication Forms (3 of 3)
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
Think About It
• Many drugs appropriate for topical administration
in adults are not appropriate for pediatric
administration
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
• Medications that affect the nervous system
– Sympathetic nervous system
 Sympathomimetics/adrenergic agonists
– Parasympathetic nervous system
 Parasympathomimetics/cholinergics
 Parasympathetic antagonists; aka parasympatholytics/
anticholinergics
Classifications of Medications (1 of 6)
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
Table 11-3
Adrenergic Receptors and Their Responses to Stimulation
Alpha1 Peripheral vasoconstriction
Alpha2 Peripheral vasodilation
Little or no bronchoconstriction
Beta1 Increased heart rate
Increased automaticity
Increased myocardial contractility
Increased conductivity
Beta2 Bronchodilation
Vasodilation
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
Classifications of Medications (2 of 6)
• Analgesics
– Medications that reduce pain
– Nonsteroidal anti-inflammatory drugs (NSAIDs)
• Anti-anxiety and sedative-hypnotic
– Designed to reduce anxiety
– Barbiturates, benzodiazepines, nonbarbiturate
hypnotics
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
• Stimulants
– Central nervous system excitation
– Caffeine, cocaine, amphetamine
• Depressants
– Slow CNS activity
– Treat anxiety, muscle tension, stress, pain, insomnia
Classifications of Medications (3 of 6)
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
• Anticonvulsants
– Antiseizure/antiepileptic; treat seizures
• Psychotherapeutic
– Treat mental illness, anxiety disorders, psychotic
disorders
• Respiratory
– OTC medications
– Beta2-agonists
– Corticosteroids
Classifications of Medications (4 of 6)
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
• Cardiovascular
– Antidysrhythmic medications treat abnormal heart
rhythms.
– Antihypertensive medications keeps blood pressure
under control.
– Antiplatelet and anticoagulant agents reduce potential
for blood clots in coronary arteries.
– Fibrinolytic agents breakdown fibrin network of existing
blood clots.
Classifications of Medications (5 of 6)
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
• Diabetic
– Medications to control blood sugar
• Immunosuppressants
– Inhibit actions of immune system
– Decrease body’s attack on its own tissues in
autoimmune disease
– Reduce the likelihood that the body will reject
a transplanted organ
Classifications of Medications (6 of 6)
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
Medication Packaging
• Packaged to accommodate intended use.
• Protects medication during storage.
• Packaged as
– Prefilled syringes
– Vials
– Nonconstituted medications
– Ampules
– Nebules
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
Figure 11-1
Example of a prefilled syringe.
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
Figure 11-2
Examples of medication vials.
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
Figure 11-3
Examples of nonconstituted medication vials.
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
Figure 11-4
Examples of ampules.
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
Think About It
• Since medications can be administered by
different routes, they are packaged to
accommodate their intended use
• For example, since epinephrine is administered
by injection, it is commonly supplied in a
prefilled syringe
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
Pharmacokinetics (1 of 7)
• Branch of pharmacology concerned with way
drugs are absorbed, distributed, metabolized, and
eliminated from body.
• Absorption
– Medication introduced to body must first enter into
body’s circulatory system.
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
Pharmacokinetics (2 of 7)
• Distribution
– After medication enters the circulation, it must be
distributed to target tissues on which it is intended
to act.
• Biotransformation
– Chemically changing medication through metabolism
• Primary organ for metabolizing and
biotransforming medications is the liver
• Bioavailability is the amount of drug that is still
active when it reaches target tissues
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
Pharmacokinetics (3 of 7)
• Elimination
– Medications are broken down into metabolites
– Excreted from body via
 Urine
 Respiration
 Feces
 Perspiration
 Mammary glands during lactation
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
Pharmacokinetics (4 of 7)
• Pharmacodynamics (mechanism of action)
– Way specific medications achieve desired effect(s)
– Effects are the result of medication binding with cellular
receptors
• Receptor sites
– Specific receptor sites on cells activated by substances
that have affinity for particular type of receptor; inhibit
or enhance functions of the cell
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
Figure 11-5
Receptor site binding.
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
Figure 11-6
Receptor site blocked by medication with greater affinity to site.
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
Pharmacokinetics (5 of 7)
• Types of mechanisms of action
– Binding with a receptor site
– Changing the cell
– Combining with another chemical substance
– Changing metabolic pathways
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
Pharmacokinetics (6 of 7)
• Dose–response relationship
– Therapeutic threshold
 Loading dose is administered to raise level of medication in
circulation to point where desired effect occurs
– Requires administration of additional doses
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
Figure 11-7
Minimum and maximum dose for a medication over time.
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
Pharmacokinetics (7 of 7)
• Dose–response relationship (continued)
– Half-life
 Time between each dose determined by how long it takes for
body to metabolize 50% of peak concentration
– Therapeutic index
 Ratio of dose of medication lethal in 50% of population (LD50);
dose effective in 50% of population (ED50)
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
Table 10-4 (1 of 2)
Factors That Influence Medication Effects
Factor Description of Altered Response
Age Patients at the extremes of age have different responses to medications than might
be expected. Infants do not have mature organ systems, and their liver is often not mature
enough to process and metabolize drugs efficiently. Their kidney function may not remove
the medication from the body as quickly. Elderly patients often have other multiple medical
conditions, such as liver and kidney dysfunction, that result in the same effect. They may be
unable to metabolize drugs efficiently due to liver damage, and they cannot filter and
eliminate medications as rapidly because the kidneys no longer function at peak efficiency.
Gender and body mass Larger patients require more of a given medication to achieve the therapeutic dose. You will
determine the amount of medication to be administered to the patient based on body weight.
Because men tend to have a greater weight and muscle mass, they tend to require a higher
dose than women. If the weights are equal, you still may need to make a specified change in
the dose due to the different fat-to-muscle ratio for women.
Pathologic state Patients with significant liver disease or kidney failure will not experience the same drug
response as an otherwise healthy individual. You may need to make adjustments when the
patient has any significant renal or hepatic disease because he will not be able to metabolize
or eliminate the drug efficiently.
Genetic factors Patients who have a genetic disorder that affects either thyroid hormone function or growth
hormone secretion may require a dose adjustment. Any disease that affects metabolic rate
significantly alters the expected response to the medication. Idiosyncratic reactions are
thought to be because of genetic variations in the way patients respond to drugs or their
metabolites.
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
Table 10-4 (2 of 2)
Factors That Influence Medication Effects
Factor Description of Altered Response
Time of administration This is primarily of concern when the medication is administered orally. The presence
or lack of food in the digestive tract has a dramatic impact on the rate of absorption.
Medications are absorbed more rapidly on an empty stomach and more slowly when food
is present in the stomach.
Psychological effects Psychological stress may alter the rate at which the body is able to metabolize a medication.
It has been known for a long time that patients get a greater effect if they believe that the
medication will help them. Imagine the difference between telling them, “This is not very
strong, but it is all I can give you for pain” and telling them, “I am going to give you a
medication to reduce your pain. It works very quickly so I need you to tell me as soon as it
starts to work so I can monitor the effect and not give you too much.” One statement
enhances the patient’s expectation of how well the drug will work and the other diminishes it
significantly.
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
• Idiosyncratic reactions
– Unusual reactions
• Iatrogenic effect
– Adverse effects caused by treatment provided
• Tolerance
– Medication produces less of an effect over time
• Cross-tolerance
– Tolerance to medications of same classification
Factors Influencing Medication Effects (1
of 2)
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
• Habituation
– An increase in tolerance following repeated doses
• Potentiation
– Enhancement of one medication when combined with
another
• Synergism
– The enhancement of multiple medications when
combined with one another
Factors Influencing Medication Effects (2
of 2)
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
• Controlled substances tracked closely and
accounted for following strict DEA guidelines.
• Medications stored at controlled temperature and
protected from light, exposure to air, and moisture.
Medication Storage
Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved.
Chapter Summary
• The ability to identify medications by name and
classification is important and useful
• It is vital to understand how different medications
work and what effects they will have on your
patient
• You must be familiar with the various forms of
medications and how they are packaged
• Stay current with medications your patients may
be taking

More Related Content

PPTX
Alexander ch12 lecture
PPTX
Alexander ch08 lecture
PPTX
Alexander ch01 lecture
PPTX
Alexander ch10 lecture
PPTX
Alexander ch02 lecture
PPTX
Alexander ch04 lecture
PPTX
Alexander ch03 lecture
PPTX
Alexander ch21 lecture
Alexander ch12 lecture
Alexander ch08 lecture
Alexander ch01 lecture
Alexander ch10 lecture
Alexander ch02 lecture
Alexander ch04 lecture
Alexander ch03 lecture
Alexander ch21 lecture

What's hot (20)

PPTX
Alexander ch22 lecture
PPTX
Alexander ch05 lecture
PPTX
Alexander ch29 lecture
PPTX
Alexander ch25 lecture
PPTX
Alexander ch20 lecture
PPTX
Alexander ch06 lecture
PPTX
Alexander ch36 lecture
PPTX
Alexander ch32 lecture
PPTX
Alexander ch27 lecture
PPTX
Alexander ch28 lecture
PPTX
Alexander ch26 lecture
PPTX
Alexander ch17 lecture
PPTX
Alexander ch24 lecture
PPTX
Alexander ch43 lecture
PPTX
Alexander ch35 lecture
PPTX
Alexander ch31 lecture
PPTX
Alexander ch16 lecture
PPTX
Pec11 chap 23 abdominal
PPTX
Pec11 chap 17 cardiovscular emergencies
PPTX
Pec11 chap 14 pharmacology and medication administration
Alexander ch22 lecture
Alexander ch05 lecture
Alexander ch29 lecture
Alexander ch25 lecture
Alexander ch20 lecture
Alexander ch06 lecture
Alexander ch36 lecture
Alexander ch32 lecture
Alexander ch27 lecture
Alexander ch28 lecture
Alexander ch26 lecture
Alexander ch17 lecture
Alexander ch24 lecture
Alexander ch43 lecture
Alexander ch35 lecture
Alexander ch31 lecture
Alexander ch16 lecture
Pec11 chap 23 abdominal
Pec11 chap 17 cardiovscular emergencies
Pec11 chap 14 pharmacology and medication administration
Ad

Similar to Alexander ch11 lecture (20)

PPTX
Essential Medicine List
PPTX
Rx16 clinical wed_1230_1_shanehsaz_2waller
PPT
lecture_1_introduction_to_pharmacology.ppt
PPTX
Essential drug list
PPT
lecture_1_introduction_to_pharmacology_0.ppt
PPT
introduction pharmacology.ppt
PPT
PPT
pharmacology.ppt
PPTX
Essential drug concept & Rational drug use.pptx
PDF
2005 DEA FAQ's
PPT
Ethics chapter
PPTX
Rx16 advocacy tues_330_1_olsen_2raymond_3conover
PPT
Gen Pharmacology Intro Bds
PPTX
Rx15 clinical wed_1230_1_moskowitz_2hall
PPT
Orientation To Pharmacology
PDF
Phil Walls
PDF
Cl 4 salsitz
PPTX
Pharmacology Introduction and basic principles
PDF
Intro to Prevention: Psychopharmacology Guest Lecture
PPTX
2014 AEMT Intro to pharmacology cole
Essential Medicine List
Rx16 clinical wed_1230_1_shanehsaz_2waller
lecture_1_introduction_to_pharmacology.ppt
Essential drug list
lecture_1_introduction_to_pharmacology_0.ppt
introduction pharmacology.ppt
pharmacology.ppt
Essential drug concept & Rational drug use.pptx
2005 DEA FAQ's
Ethics chapter
Rx16 advocacy tues_330_1_olsen_2raymond_3conover
Gen Pharmacology Intro Bds
Rx15 clinical wed_1230_1_moskowitz_2hall
Orientation To Pharmacology
Phil Walls
Cl 4 salsitz
Pharmacology Introduction and basic principles
Intro to Prevention: Psychopharmacology Guest Lecture
2014 AEMT Intro to pharmacology cole
Ad

More from corynava00 (16)

PPTX
Alexander ch47 lecture
PPTX
Alexander ch46 lecture
PPTX
Alexander ch45 lecture
PPTX
Alexander ch44 lecture
PPTX
Alexander ch42 lecture
PPTX
Alexander ch41 lecture
PPTX
Alexander ch40 lecture
PPTX
Alexander ch39 lecture
PPTX
Alexander ch38 lecture
PPTX
Alexander ch37 lecture
PPTX
Alexander ch34 lecture
PPTX
Alexander ch33 lecture
PPTX
Alexander ch30 lecture
PPTX
Alexander ch23 lecture
PPTX
Alexander ch19 lecture
PPTX
Alexander ch18 lecture
Alexander ch47 lecture
Alexander ch46 lecture
Alexander ch45 lecture
Alexander ch44 lecture
Alexander ch42 lecture
Alexander ch41 lecture
Alexander ch40 lecture
Alexander ch39 lecture
Alexander ch38 lecture
Alexander ch37 lecture
Alexander ch34 lecture
Alexander ch33 lecture
Alexander ch30 lecture
Alexander ch23 lecture
Alexander ch19 lecture
Alexander ch18 lecture

Recently uploaded (20)

PDF
Myers’ Psychology for AP, 1st Edition David G. Myers Test Bank.pdf
PPT
Adrenergic drugs (sympathomimetics ).ppt
PPTX
1. Drug Distribution System.pptt b pharmacy
PDF
DAY-6. Summer class. Ppt. Cultural Nursing
PPTX
Galactosemia pathophysiology, clinical features, investigation and treatment ...
PPTX
Trichuris trichiura infection
PPT
Pyramid Points Lab Values Power Point(11).ppt
PPTX
First Aid and Basic Life Support Training.pptx
PPTX
Bronchial_Asthma_in_acute_exacerbation_.pptx
PDF
Khaled Sary- Trailblazers of Transformation Middle East's 5 Most Inspiring Le...
PPTX
Medical aspects of impairment including all the domains mentioned in ICF
PPTX
Current Treatment Of Heart Failure By Dr Masood Ahmed
PPTX
Pulmonary Circulation PPT final for easy
PPTX
NUTRITIONAL PROBLEMS, CHANGES NEEDED TO PREVENT MALNUTRITION
PPT
Parental-Carer-mental-illness-and-Potential-impact-on-Dependant-Children.ppt
PDF
NUTRITION THROUGHOUT THE LIFE CYCLE CHILDHOOD -AGEING
PPT
Recent advances in Diagnosis of Autoimmune Disorders
PPTX
Vaginal Bleeding and Uterine Fibroids p
PPTX
Rheumatic heart diseases with Type 2 Diabetes Mellitus
PDF
Dermatology diseases Index August 2025.pdf
Myers’ Psychology for AP, 1st Edition David G. Myers Test Bank.pdf
Adrenergic drugs (sympathomimetics ).ppt
1. Drug Distribution System.pptt b pharmacy
DAY-6. Summer class. Ppt. Cultural Nursing
Galactosemia pathophysiology, clinical features, investigation and treatment ...
Trichuris trichiura infection
Pyramid Points Lab Values Power Point(11).ppt
First Aid and Basic Life Support Training.pptx
Bronchial_Asthma_in_acute_exacerbation_.pptx
Khaled Sary- Trailblazers of Transformation Middle East's 5 Most Inspiring Le...
Medical aspects of impairment including all the domains mentioned in ICF
Current Treatment Of Heart Failure By Dr Masood Ahmed
Pulmonary Circulation PPT final for easy
NUTRITIONAL PROBLEMS, CHANGES NEEDED TO PREVENT MALNUTRITION
Parental-Carer-mental-illness-and-Potential-impact-on-Dependant-Children.ppt
NUTRITION THROUGHOUT THE LIFE CYCLE CHILDHOOD -AGEING
Recent advances in Diagnosis of Autoimmune Disorders
Vaginal Bleeding and Uterine Fibroids p
Rheumatic heart diseases with Type 2 Diabetes Mellitus
Dermatology diseases Index August 2025.pdf

Alexander ch11 lecture

  • 1. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. Advanced EMT A Clinical-Reasoning Approach, 2nd Edition Chapter 11 Principles of Pharmacology
  • 2. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. • The Advanced EMT applies fundamental knowledge of medications in the Advanced EMT scope of practice to patient assessment and management. Advanced EMT Education Standard
  • 3. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. 1. Define key terms introduced in this chapter. 2. Give examples of each of the four sources of drugs. 3. Explain the role of the U.S. Food and Drug Administration in the development and continued oversight of drugs. 4. Discuss relevant legislation regarding the administration of prescription medications, including controlled substances. 5. Identify the official, generic, and trade names of drugs in the Advanced EMT scope of practice. Objectives (1 of 3)
  • 4. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. 6. Describe the various forms in which drugs are supplied. 7. Describe the various types of medication packaging. 8. Explain each of the components of a drug profile. 9. Explain each of the following with respect to pharmacology: drug absorption, drug distribution, mechanism of action, and drug elimination. 10.Explain the roles of the kidneys and liver in drug metabolism and excretion. Objectives (2 of 3)
  • 5. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. 11.Explain factors that can affect the concentration of a drug in a patient’s body. 12.Describe the concepts of drug receptor sites and protein binding of medications. 13.Identify special populations in whom the administration of drugs may need to be modified. Objectives (3 of 3)
  • 6. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. • AEMTs are responsible for administering medications to ill and injured patients • Some medications, administered incorrectly, produce life-threatening consequences • Must have understanding of pharmacology • Pharmacology – Study of origin, nature, properties, actions of drugs and their effects on living organisms Introduction
  • 7. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. • What are some initial hypotheses about the cause of the problem? • What additional information would assist Mike and Matt in determining the cause of the patient’s condition? • What initial steps in management should the crew members take as they finish their assessment? Think About It
  • 8. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. • Four basic sources of medications – Plant – Animal – Mineral – Synthetic Medication Sources
  • 9. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. • Discovered in 1921, insulin has saved the lives of 15 million people with diabetes • Insulin is mainly derived from the pancreas of pigs and cows Think About It
  • 10. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. • Keep knowledge current by reviewing new medication information • Be familiar with reliable, up-to-date sources – Physician’s Desk Reference (PDR) – American Medical Association (AMA) drug evaluations – Hospital Formulary Medication Reference Material
  • 11. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. • Consists of – Medication name – Classification – Mechanism of action – Indications – Pharmacokinetics – Side effects – Routes of administration – Contraindications – Dose – How the drug is supplied – Special considerations Medication Profile (1 of 5)
  • 12. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. • Medication name – Generic name – Trade name – Chemical name • Classification – Type of medication it is – Different classification schemes used – Mechanism of action – Body system it works within Medication Profile (2 of 5)
  • 13. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. • Mechanism of action – Way medication achieves its intended effects • Indications – Conditions that medication intended to treat • Pharmacokinetics – How the drug is absorbed, distributed to tissues, eliminated from the body • Side effects – Unintended effects of medication Medication Profile (3 of 5)
  • 14. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. • Route of administration – Way medication introduced into the body • Contraindications – Makes administration of drug harmful, even though otherwise indicated for the medical problem • Dose – Amount and frequency of medication to be administered Medication Profile (4 of 5)
  • 15. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. • How supplied – Packaging and concentrations available • Special considerations – Special precautions to be observed when administering drug to special patient populations Medication Profile (5 of 5)
  • 16. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. Medication Oversight and Regulation (1 of 6) • Legislation – Protect the public from unsafe and mislabeled medications • The Harrison Narcotic Act of 1914 – Regulations on importation, manufacture, sale, and use of medications
  • 17. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. Medication Oversight and Regulation (2 of 6) • The Food, Drug, and Cosmetic Act of 1938 – Provided additional protection to the public – Revised in 1952 and 1962 – Provided for:  Formation of FDA  Mandated prescriptions required for addictive or harmful medications  Required labeling of medications that include addictive drugs and potential side effects
  • 18. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. Medication Oversight and Regulation (3 of 6) • Durham-Humphrey Amendments were added to 1938 Act – Added in 1951 – Required pharmacists to dispense certain medication only by prescription – Defined OTC medications
  • 19. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. Medication Oversight and Regulation (4 of 6) • The Comprehensive Drug Abuse Prevention and Control Act of 1970 – Aka Controlled Substances Act – Replaced the Harrison Narcotic Act of 1914 – Includes five schedules of controlled substances based upon their potential for abuse – Schedule I drugs have highest potential while Schedule IV drugs have least potential
  • 20. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. Table 11-1 (1 of 2) Schedules of Controlled Substances Schedule I Schedule I medications have a high potential for abuse and do not have any recognized medical use in the United States. Examples: heroin, LSD, mescaline, methaqualone Schedule II Schedule II medications have a high potential for abuse but also have a recognized medical use in the United States. These medications require a written prescription, are restricted from phone renewals, and require oversight by a physician. Abuse may result in severe physical or psychological dependence. Examples: morphine, codeine, meperidine, hydrocodone, and a host of very addictive stimulants and depressants Schedule III Schedule III medications have less abuse potential than Schedule II medications and an accepted medical use. Abuse can result in moderate to low physical or psychological dependence. Examples: anabolic steroids, nonprescription painkillers combined with small amounts of Schedule II substances such as acetaminophen with codeine or hydrocodone; also medications that contain small amounts of opiates
  • 21. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. Table 11-1 (2 of 2) Schedules of Controlled Substances SCHEDULE IV Schedule IV medications have less abuse potential than Schedule III medications and an accepted medical use. Abuse can result in less physical or psychological dependence than drugs in Schedule III. Examples: benzodiazepines, some barbiturates, steroids, stimulants SCHEDULE V Schedule V medications have less abuse potential than Schedule IV medications and an accepted medical use. Abuse can result in less physical or psychological dependence than drugs in Schedule IV. Examples: over-the-counter (OTC) medications for cough or antidiarrheal medications that contain small amounts of controlled substances Source: U.S. Drug Enforcement Administration. n.d. “Drug Scheduling.” A Drug Info page on the DEA website. http://www.dea/gov/druginfo/ds.shtml
  • 22. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. • Medication safety and regulation – The FDA is responsible for testing new medications; food safety; testing of new medical devices; cosmetics safety – Testing phases  Phase I  Phase II  Phase III  Phase IV Medication Oversight and Regulation (5 of 6)
  • 23. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. • Special considerations – Pregnant patient  Changes in anatomy and physiology  Risk to the fetus – Pediatric patients  Physical differences between adult and child  Differences on how medications affect children  Pediatric drug dosing based on weight of patient – Geriatric patients  Differences in absorption, distribution, metabolism, and elimination of medication  Multiple medical conditions requiring medications Medication Oversight and Regulation (6 of 6)
  • 24. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. Table 11-2 FDA Pregnancy Categories Category Description A Studies have not identified a risk to the fetus during pregnancy. B Animal studies have not identified a risk to the fetus but there are no adequate human studies. OR Adequate studies in humans have not demonstrated a risk to the fetus during pregnancy but animal studies have produced adverse effects. C Animal studies have demonstrated adverse effects but there are no adequate studies in pregnant women; however, benefits may be acceptable despite the potential risks. OR No adequate animal studies or adequate studies of pregnant women have been performed. D Studies have shown risk to the fetus. In some situations, benefits could outweigh the risks. X Studies have shown risk to the fetus. This risk outweighs any potential benefit to the mother. Avoid using these medications in pregnant or potentially pregnant patients. Source: Gunatilake, R,, and A. S. Patel. n.d. “Drugs in Pregnancy.” A Gynecology and Obstretrics page on the Merck Manual Professional Version website. Last updated January 2013. http://www.merckmanuals.com
  • 25. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. Medication Names • Trade name – Proventil ® • Chemical name – α1 [(tert-butyl amino) methyl]-4-hydroxy-m- xylene-α,α,́-diol sulfate (2:1) (salt) • Generic name – Albuterol sulfate • Official name – Albuterol sulfate USP
  • 26. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. • Solid medications – Tablet – Capsule – Powder Medication Forms (1 of 3)
  • 27. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. Medication Forms (2 of 3) • Liquid medications – Suspensions – Tinctures – Spirits – Elixirs – Syrups – Emulsions
  • 28. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. • Semisolid medications – Lotions – Creams – Gels – Ointments – Medicated adhesive patches • Gases – Oxygen – Nitrous oxide Medication Forms (3 of 3)
  • 29. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. Think About It • Many drugs appropriate for topical administration in adults are not appropriate for pediatric administration
  • 30. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. • Medications that affect the nervous system – Sympathetic nervous system  Sympathomimetics/adrenergic agonists – Parasympathetic nervous system  Parasympathomimetics/cholinergics  Parasympathetic antagonists; aka parasympatholytics/ anticholinergics Classifications of Medications (1 of 6)
  • 31. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. Table 11-3 Adrenergic Receptors and Their Responses to Stimulation Alpha1 Peripheral vasoconstriction Alpha2 Peripheral vasodilation Little or no bronchoconstriction Beta1 Increased heart rate Increased automaticity Increased myocardial contractility Increased conductivity Beta2 Bronchodilation Vasodilation
  • 32. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. Classifications of Medications (2 of 6) • Analgesics – Medications that reduce pain – Nonsteroidal anti-inflammatory drugs (NSAIDs) • Anti-anxiety and sedative-hypnotic – Designed to reduce anxiety – Barbiturates, benzodiazepines, nonbarbiturate hypnotics
  • 33. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. • Stimulants – Central nervous system excitation – Caffeine, cocaine, amphetamine • Depressants – Slow CNS activity – Treat anxiety, muscle tension, stress, pain, insomnia Classifications of Medications (3 of 6)
  • 34. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. • Anticonvulsants – Antiseizure/antiepileptic; treat seizures • Psychotherapeutic – Treat mental illness, anxiety disorders, psychotic disorders • Respiratory – OTC medications – Beta2-agonists – Corticosteroids Classifications of Medications (4 of 6)
  • 35. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. • Cardiovascular – Antidysrhythmic medications treat abnormal heart rhythms. – Antihypertensive medications keeps blood pressure under control. – Antiplatelet and anticoagulant agents reduce potential for blood clots in coronary arteries. – Fibrinolytic agents breakdown fibrin network of existing blood clots. Classifications of Medications (5 of 6)
  • 36. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. • Diabetic – Medications to control blood sugar • Immunosuppressants – Inhibit actions of immune system – Decrease body’s attack on its own tissues in autoimmune disease – Reduce the likelihood that the body will reject a transplanted organ Classifications of Medications (6 of 6)
  • 37. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. Medication Packaging • Packaged to accommodate intended use. • Protects medication during storage. • Packaged as – Prefilled syringes – Vials – Nonconstituted medications – Ampules – Nebules
  • 38. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. Figure 11-1 Example of a prefilled syringe.
  • 39. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. Figure 11-2 Examples of medication vials.
  • 40. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. Figure 11-3 Examples of nonconstituted medication vials.
  • 41. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. Figure 11-4 Examples of ampules.
  • 42. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. Think About It • Since medications can be administered by different routes, they are packaged to accommodate their intended use • For example, since epinephrine is administered by injection, it is commonly supplied in a prefilled syringe
  • 43. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. Pharmacokinetics (1 of 7) • Branch of pharmacology concerned with way drugs are absorbed, distributed, metabolized, and eliminated from body. • Absorption – Medication introduced to body must first enter into body’s circulatory system.
  • 44. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. Pharmacokinetics (2 of 7) • Distribution – After medication enters the circulation, it must be distributed to target tissues on which it is intended to act. • Biotransformation – Chemically changing medication through metabolism • Primary organ for metabolizing and biotransforming medications is the liver • Bioavailability is the amount of drug that is still active when it reaches target tissues
  • 45. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. Pharmacokinetics (3 of 7) • Elimination – Medications are broken down into metabolites – Excreted from body via  Urine  Respiration  Feces  Perspiration  Mammary glands during lactation
  • 46. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. Pharmacokinetics (4 of 7) • Pharmacodynamics (mechanism of action) – Way specific medications achieve desired effect(s) – Effects are the result of medication binding with cellular receptors • Receptor sites – Specific receptor sites on cells activated by substances that have affinity for particular type of receptor; inhibit or enhance functions of the cell
  • 47. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. Figure 11-5 Receptor site binding.
  • 48. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. Figure 11-6 Receptor site blocked by medication with greater affinity to site.
  • 49. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. Pharmacokinetics (5 of 7) • Types of mechanisms of action – Binding with a receptor site – Changing the cell – Combining with another chemical substance – Changing metabolic pathways
  • 50. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. Pharmacokinetics (6 of 7) • Dose–response relationship – Therapeutic threshold  Loading dose is administered to raise level of medication in circulation to point where desired effect occurs – Requires administration of additional doses
  • 51. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. Figure 11-7 Minimum and maximum dose for a medication over time.
  • 52. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. Pharmacokinetics (7 of 7) • Dose–response relationship (continued) – Half-life  Time between each dose determined by how long it takes for body to metabolize 50% of peak concentration – Therapeutic index  Ratio of dose of medication lethal in 50% of population (LD50); dose effective in 50% of population (ED50)
  • 53. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. Table 10-4 (1 of 2) Factors That Influence Medication Effects Factor Description of Altered Response Age Patients at the extremes of age have different responses to medications than might be expected. Infants do not have mature organ systems, and their liver is often not mature enough to process and metabolize drugs efficiently. Their kidney function may not remove the medication from the body as quickly. Elderly patients often have other multiple medical conditions, such as liver and kidney dysfunction, that result in the same effect. They may be unable to metabolize drugs efficiently due to liver damage, and they cannot filter and eliminate medications as rapidly because the kidneys no longer function at peak efficiency. Gender and body mass Larger patients require more of a given medication to achieve the therapeutic dose. You will determine the amount of medication to be administered to the patient based on body weight. Because men tend to have a greater weight and muscle mass, they tend to require a higher dose than women. If the weights are equal, you still may need to make a specified change in the dose due to the different fat-to-muscle ratio for women. Pathologic state Patients with significant liver disease or kidney failure will not experience the same drug response as an otherwise healthy individual. You may need to make adjustments when the patient has any significant renal or hepatic disease because he will not be able to metabolize or eliminate the drug efficiently. Genetic factors Patients who have a genetic disorder that affects either thyroid hormone function or growth hormone secretion may require a dose adjustment. Any disease that affects metabolic rate significantly alters the expected response to the medication. Idiosyncratic reactions are thought to be because of genetic variations in the way patients respond to drugs or their metabolites.
  • 54. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. Table 10-4 (2 of 2) Factors That Influence Medication Effects Factor Description of Altered Response Time of administration This is primarily of concern when the medication is administered orally. The presence or lack of food in the digestive tract has a dramatic impact on the rate of absorption. Medications are absorbed more rapidly on an empty stomach and more slowly when food is present in the stomach. Psychological effects Psychological stress may alter the rate at which the body is able to metabolize a medication. It has been known for a long time that patients get a greater effect if they believe that the medication will help them. Imagine the difference between telling them, “This is not very strong, but it is all I can give you for pain” and telling them, “I am going to give you a medication to reduce your pain. It works very quickly so I need you to tell me as soon as it starts to work so I can monitor the effect and not give you too much.” One statement enhances the patient’s expectation of how well the drug will work and the other diminishes it significantly.
  • 55. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. • Idiosyncratic reactions – Unusual reactions • Iatrogenic effect – Adverse effects caused by treatment provided • Tolerance – Medication produces less of an effect over time • Cross-tolerance – Tolerance to medications of same classification Factors Influencing Medication Effects (1 of 2)
  • 56. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. • Habituation – An increase in tolerance following repeated doses • Potentiation – Enhancement of one medication when combined with another • Synergism – The enhancement of multiple medications when combined with one another Factors Influencing Medication Effects (2 of 2)
  • 57. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. • Controlled substances tracked closely and accounted for following strict DEA guidelines. • Medications stored at controlled temperature and protected from light, exposure to air, and moisture. Medication Storage
  • 58. Copyright © 2017, 2012 Pearson Education, Inc. All Rights Reserved. Chapter Summary • The ability to identify medications by name and classification is important and useful • It is vital to understand how different medications work and what effects they will have on your patient • You must be familiar with the various forms of medications and how they are packaged • Stay current with medications your patients may be taking